NOVEL VACCINES AGAINST MULTIPLE SUBTYPES OF DENGUE VIRUS
    3.
    发明申请
    NOVEL VACCINES AGAINST MULTIPLE SUBTYPES OF DENGUE VIRUS 有权
    新型疫苗对抗多种病毒的宿主病毒

    公开(公告)号:US20100291144A1

    公开(公告)日:2010-11-18

    申请号:US12812268

    申请日:2009-01-12

    摘要: An aspect of the present invention is related to nucleic acid constructs capable of expressing a polypeptide that elicits an immune response in a mammal against more than one subtype of dengue virus, and methods of use thereof. Additionally, there are DNA plasmid vaccines capable of generating in a mammal an immune response against a plurality of dengue virus subtypes, comprising a DNA plasmid and a pharmaceutically acceptable excipient, and methods of use thereof. The DNA plasmid is capable of expressing a consensus dengue antigen in a cell of the mammal in a quantity effective to elicit an immune response in the mammal.

    摘要翻译: 本发明的一个方面涉及能够表达在哺乳动物中针对多于一种登革热病毒亚型引起免疫应答的多肽的核酸构建体及其使用方法。 此外,存在能够在哺乳动物中产生针对多种登革热病毒亚型的免疫应答的DNA质粒疫苗,其包含DNA质粒和药学上可接受的赋形剂及其使用方法。 DNA质粒能够以有效引发哺乳动物免疫应答的量在哺乳动物细胞中表达一致性登革热抗原。